Cardiology
Chronic Atrial Fibrillation Management
NICE NG196 / ESC 2024 — rate vs rhythm control, anticoagulation by CHA₂DS₂-VASc, ablation, lifestyle.
Source: NICE NG196; ESC 2024 AF Guidelines
Used in: Atrial Fibrillation
Step 1 of ~8
info
Confirm Diagnosis & Type
12-lead ECG / 24h Holter / wearable monitor. Classify: paroxysmal (terminates <7 days, usually <48h), persistent (>7 days), long-standing persistent (>12 months), permanent (accepted, no further rhythm control). Investigate: TFTs, U&E, FBC, BNP, echo (LV function, valve disease, atrial size).
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Insulin (IV Infusion — ICU Glucose Control) · Insulin — ICU Glucose Management
- Sodium Chloride 3% (Hypertonic Saline) · Hypertonic Electrolyte Solution — ICP/Hyponatraemia Management
- Bivalirudin (PCI Anticoagulation) · Direct Thrombin Inhibitor / PCI
- Vernakalant · Atrial-selective antiarrhythmic
- Omalizumab (Dermatology — Chronic Urticaria) · Anti-IgE Monoclonal Antibody
- Bivalirudin · Anticoagulation
Pathways
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Featured in these MRCEM clinical pathways
A deeper exam-focused version of this pathway is available on our sister siteReviseMRCEM.
MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.
Decision support only. Always apply local guidelines and clinical judgement.